OSCR

Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology.

Overview

Authors: Leeor S Yefet1,2,3,4, Alexander P Landry1,3,4, Justin Z Wang1,3,4, Jeff Liu3,4, Vikas Patil3,4, Chloe Gui1,3,4, Andrew Ajisebutu1,3,4, Yosef Ellenbogen1,3,4, Yasin Mamatjan4,5, Rebecca Yakubov3,4, Ramneet Kaloti3,4, Phooja Persaud3,4, Qingxia Wei3,4, Olivia Singh2, Sheila Mansouri3,4, Severa Bunda3,4, Aaron A Cohen-Gadol6, Ghazaleh Tabatabai7,8,9, Marcos Tatagiba10, Felix Behling10
and 13 other authorsJill S Barnholtz-Sloan11,12, Andrew E Sloan13, Silky Chotai14, Lola B Chambless14, Alireza Mansouri15, Sameer Agnihotri16, Serge Makarenko17, Stephen Yip17, Derek S Tsang18, Kenneth Aldape19, Andrew Gao20, Farshad Nassiri1,3,4, Gelareh Zadeh1,2,3,4
20 affiliations
  1. Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, ON, Canada (L.S.Y., A.P.L., J.Z.W., C.G., A.A., Y.E., F.N., G.Z.)
  2. Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA (L.S.Y., O.S., G.Z.)
  3. Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada (L.S.Y., A.P.L., J.Z.W., J.L., V.P., C.G., A.A., Y.E., R.Y., R.K, P.P., Q.W., S.M., S.B., F.N, G.Z.)
  4. MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada (L.S.Y., A.P.L., J.Z.W., J.L., V.P., C.G., A.A., Y.E., Y.M., R.Y., R.K, P.P., Q.W., S.M., S.B., F.N, G.Z.)
  5. Department of Engineering, Thompson Rivers University, Kamloops, BC, Canada (Y.M.)
  6. Department of Neurological Surgery, Keck School of Medicine, USC, Los Angeles, CA, USA (A.A.C.-G.)
  7. Department of Neurology and Interdisciplinary Neuro-Oncology, Center for Neuro-Oncology, Comprehensive Cancer Center, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany (G.T.)
  8. Cluster of Excellence (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies,”, Eberhard Karls University Tübingen, Tübingen, Germany (G.T.)
  9. German Cancer Consortium (DKTK), Partner Site Tübingen, a Partnership Between DKFZ and Tübingen University Hospital, Tübingen, Germany (G.T.)
  10. Department of Neurosurgery, Center for Neuro-Oncology, Comprehensive Cancer Center, Eberhard Karls University Tübingen, Tübingen, Germany (M.T., F.B.)
  11. Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute, Bethesda, MD, USA (J.S.B.-S.)
  12. Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, Bethesda, MD, USA (J.S.B.-S.)
  13. Department of Neurological Surgery & Piedmont, Brain Tumor Center, Atlanta, GA, USA (A.E.S.)
  14. Department of Neurosurgery, Vanderbilt University Medical Center, Nashville, TN, USA (S.C., L.B.C.)
  15. Department of Neurosurgery, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA (A.M.)
  16. Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA (S.A.)
  17. Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada (S.M., S.Y.)
  18. Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada (D.S.T.)
  19. Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA (K.A.)
  20. Division of Laboratory Medicine and Pathobiology, University Health Network, Toronto, ON, Canada (A.G.)
Journal: Neuro-oncology, volume 28, issue 3, pages 765-775
Dates: received 29 July 2025; accepted 9 October 2025; published online 8 November 2025; in print March 2026
Type: Research article · Language: English
License: CC BY-NC
Identifiers: DOI 10.1093/neuonc/noaf252 · PMID 41206747 · PMCID PMC13070492 · OpenAlex W4416098832
Open access: hybrid, a free copy (OpenAlex)
Status: code on request
Categories: genetics / omics (modality), human (organism), other condition (population), developmental (subfield)
Methods: Statistics, Machine learning, Connectivity
Keywords: adolescent and young adult (AYA), DNA methylation, meningioma, neuro-oncology, pediatric
MeSH: Biomarkers, Tumor*, DNA Methylation*, Meningeal Neoplasms*, Meningioma*, Neoplasm Recurrence, Local*, Adolescent, Adult, Child, DNA Copy Number Variations, Female, Follow-Up Studies, Humans, Male, Prognosis, Survival Rate, Young Adult (* major topic)
Topic: Meningioma and schwannoma management (Epidemiology, Medicine), according to OpenAlex
Funding: Canadian Institutes of Health Research and Brain Tumour Charity
Citations: not cited yet (Europe PMC); 34 references in the paper

Abstract

Background: Adolescent and young adult (AYA) patients remain underrepresented in neuro-oncology research. Despite being the second most common primary brain tumor in this population, meningiomas have not been studied using age-specific molecular analyses. DNA methylation-based classification and prognostic tools have transformed meningioma care. This study aimed to evaluate the performance of these tools across age groups.

Methods: We analyzed 1,568 meningiomas with DNA methylation and clinical data, including 18 pediatric patients (<15 years), 195 AYA patients (15-39 years), and 1,355 adult patients (>39 years). Pediatric and AYA (P/AYA) tumors were combined and compared with adult tumors. The performance of established molecular classifiers and recurrence predictors, as well as differences in chromosomal copy number alterations were compared across age groups.

Results: While histologic grading was comparable between cohorts, P/AYA tumors displayed significantly fewer aggressive molecular groups and lower frequencies of chromosomal arm losses, including 1p, 6q, and 14q. The adult-trained recurrence predictor failed in the P/AYA population (AUC 0.57), despite similar score distributions. Retraining the model on an age-specific cohort using an identical analytic framework improved performance (AUC 0.79) and enabled effective stratification of progression-free survival (P = 0.00054). Importantly, 1p loss retained prognostic significance within the P/AYA group, supporting its clinical utility.

Conclusions: Molecular tools developed in adult-dominant cohorts do not generalize to younger patients due to both biological divergence and exclusion from model development. These findings underscore the need for age-specific molecular frameworks and highlight the imperative of including P/AYA populations in precision neuro-oncology research to ensure lifespan-equitable care.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

Datasets cited

Data Availability

Data and source code will be made available on Zenodo at time of publication.

Reproduced under the paper's license (CC BY-NC), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 30 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 33 authors, 5 keywords, 16 MeSH terms, 1 funder, 34 references.

Cite

This paper

Yefet, L. S., Landry, A. P., Wang, J. Z., Liu, J., Patil, V., Gui, C., Ajisebutu, A., Ellenbogen, Y., Mamatjan, Y., Yakubov, R., Kaloti, R., Persaud, P., Wei, Q., Singh, O., Mansouri, S., Bunda, S., Cohen-Gadol, A. A., Tabatabai, G., Tatagiba, M., . . . Zadeh, G. (2026). Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology. Neuro-oncology, 28(3), 765-775. https://doi.org/10.1093/neuonc/noaf252

BibTeX

@article{yefet2026assessment,
author = {Yefet, Leeor S and Landry, Alexander P and Wang, Justin Z and Liu, Jeff and Patil, Vikas and Gui, Chloe and Ajisebutu, Andrew and Ellenbogen, Yosef and Mamatjan, Yasin and Yakubov, Rebecca and Kaloti, Ramneet and Persaud, Phooja and Wei, Qingxia and Singh, Olivia and Mansouri, Sheila and Bunda, Severa and Cohen-Gadol, Aaron A and Tabatabai, Ghazaleh and Tatagiba, Marcos and Behling, Felix and Barnholtz-Sloan, Jill S and Sloan, Andrew E and Chotai, Silky and Chambless, Lola B and Mansouri, Alireza and Agnihotri, Sameer and Makarenko, Serge and Yip, Stephen and Tsang, Derek S and Aldape, Kenneth and Gao, Andrew and Nassiri, Farshad and Zadeh, Gelareh},
title = {{Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology}},
journal = {Neuro-oncology},
year = {2026},
month = mar,
volume = {28},
number = {3},
pages = {765--775},
publisher = {Oxford University Press},
issn = {1522-8517},
doi = {10.1093/neuonc/noaf252},
url = {https://doi.org/10.1093/neuonc/noaf252},
pmid = {41206747},
pmcid = {PMC13070492}
}

RIS

TY - JOUR
AU - Yefet, Leeor S
AU - Landry, Alexander P
AU - Wang, Justin Z
AU - Liu, Jeff
AU - Patil, Vikas
AU - Gui, Chloe
AU - Ajisebutu, Andrew
AU - Ellenbogen, Yosef
AU - Mamatjan, Yasin
AU - Yakubov, Rebecca
AU - Kaloti, Ramneet
AU - Persaud, Phooja
AU - Wei, Qingxia
AU - Singh, Olivia
AU - Mansouri, Sheila
AU - Bunda, Severa
AU - Cohen-Gadol, Aaron A
AU - Tabatabai, Ghazaleh
AU - Tatagiba, Marcos
AU - Behling, Felix
AU - Barnholtz-Sloan, Jill S
AU - Sloan, Andrew E
AU - Chotai, Silky
AU - Chambless, Lola B
AU - Mansouri, Alireza
AU - Agnihotri, Sameer
AU - Makarenko, Serge
AU - Yip, Stephen
AU - Tsang, Derek S
AU - Aldape, Kenneth
AU - Gao, Andrew
AU - Nassiri, Farshad
AU - Zadeh, Gelareh
TI - Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology
T2 - Neuro-oncology
J2 - Neuro Oncol
PY - 2026
DA - 2026/03/01
VL - 28
IS - 3
SP - 765
EP - 775
SN - 1522-8517
PB - Oxford University Press
DO - 10.1093/neuonc/noaf252
UR - https://doi.org/10.1093/neuonc/noaf252
LA - en
ER -

CSL-JSON

{
"id": "10.1093/neuonc/noaf252",
"type": "article-journal",
"title": "Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology",
"container-title": "Neuro-oncology",
"author": [
{
"family": "Yefet",
"given": "Leeor S"
},
{
"family": "Landry",
"given": "Alexander P"
},
{
"family": "Wang",
"given": "Justin Z"
},
{
"family": "Liu",
"given": "Jeff"
},
{
"family": "Patil",
"given": "Vikas"
},
{
"family": "Gui",
"given": "Chloe"
},
{
"family": "Ajisebutu",
"given": "Andrew"
},
{
"family": "Ellenbogen",
"given": "Yosef"
},
{
"family": "Mamatjan",
"given": "Yasin"
},
{
"family": "Yakubov",
"given": "Rebecca"
},
{
"family": "Kaloti",
"given": "Ramneet"
},
{
"family": "Persaud",
"given": "Phooja"
},
{
"family": "Wei",
"given": "Qingxia"
},
{
"family": "Singh",
"given": "Olivia"
},
{
"family": "Mansouri",
"given": "Sheila"
},
{
"family": "Bunda",
"given": "Severa"
},
{
"family": "Cohen-Gadol",
"given": "Aaron A"
},
{
"family": "Tabatabai",
"given": "Ghazaleh"
},
{
"family": "Tatagiba",
"given": "Marcos"
},
{
"family": "Behling",
"given": "Felix"
},
{
"family": "Barnholtz-Sloan",
"given": "Jill S"
},
{
"family": "Sloan",
"given": "Andrew E"
},
{
"family": "Chotai",
"given": "Silky"
},
{
"family": "Chambless",
"given": "Lola B"
},
{
"family": "Mansouri",
"given": "Alireza"
},
{
"family": "Agnihotri",
"given": "Sameer"
},
{
"family": "Makarenko",
"given": "Serge"
},
{
"family": "Yip",
"given": "Stephen"
},
{
"family": "Tsang",
"given": "Derek S"
},
{
"family": "Aldape",
"given": "Kenneth"
},
{
"family": "Gao",
"given": "Andrew"
},
{
"family": "Nassiri",
"given": "Farshad"
},
{
"family": "Zadeh",
"given": "Gelareh"
}
],
"container-title-short": "Neuro Oncol",
"volume": "28",
"issue": "3",
"page": "765-775",
"DOI": "10.1093/neuonc/noaf252",
"PMID": "41206747",
"PMCID": "PMC13070492",
"ISSN": "1522-8517",
"publisher": "Oxford University Press",
"URL": "https://doi.org/10.1093/neuonc/noaf252",
"language": "en",
"issued": {
"date-parts": [
[
2026,
3,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41467-026-77170-3 [code]
DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression.
Journal: Nature communications
In common: genetics / omics, other condition, 8 references
[2] doi:10.1021/acs.jproteome.5c01173
Proteomic Analysis Identifies ATE1-Dependent Arginylation Dysregulation across Meningioma Grades.
Journal: Journal of proteome research
In common: NCBI GEO GSE136661, genetics / omics, other condition, 1 reference
[3] doi:10.1016/j.xcrm.2026.102682 [code]
TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas.
Journal: Cell reports. Medicine
In common: genetics / omics, other condition, 2 references
[4] doi:10.1002/adhm.202504889 [code]
Mapping the Cerebral Organoid Landscape: A Systematic Review of Preclinical 3D Models in Neuroscience.
Journal: Advanced healthcare materials
In common: developmental, other condition, 1 reference
[5] doi:10.1186/s12943-026-02612-x [code]
Modeling pediatric low-grade glioma heterogeneity using human forebrain organoids.
Journal: Molecular cancer
In common: genetics / omics, other condition, 1 reference
[6] doi:10.1002/acm2.70560 [code]
Hybrid CNN-GCN framework for brain tumor MRI classification: A graph-based approach to smart healthcare diagnostics.
Journal: Journal of applied clinical medical physics
In common: other condition, 1 reference
[7] doi:10.1038/s41593-026-02316-x [code]
Single-cell multi-omic atlas and morphogen screening informs midbrain and hindbrain organoid engineering.
Journal: Nature neuroscience
In common: genetics / omics, 1 reference
[8] doi:10.1093/braincomms/fcag317 [code]
Deep learning segmentation of paediatric brain tumours using diffusion-weighted MRI: towards an early, &lt;i&gt;in vivo&lt;/i&gt; classification pipeline.
Journal: Brain communications
In common: other condition, 1 reference
[9] doi:10.1016/j.ebiom.2026.106408 [code]
Microcephaly-like phenotype triggered by novel reassortant and prototypic Oropouche virus strains in brain organoids.
Journal: EBioMedicine
In common: developmental, genetics / omics, other condition
[10] doi:10.1016/j.mocell.2026.100387
USP15 mutation associated with autism spectrum disorder alters progenitor fate and neuronal maturation in human brain organoids.
Journal: Molecules and cells
In common: developmental, genetics / omics, other condition

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.